Star-Shaped Polymers Kill Antibiotic Resistant Bacteria
| By HospiMedica International staff writers Posted on 05 Oct 2016 | 

Image: A bacteria cell before (L) and after treatment (R) with star-shaped polymers (Photo courtesy of UNIMELB).
			
			A new study suggests that structurally nanoengineered antimicrobial peptide polymers (SNAPPs) could provide a low-cost and effective antimicrobial agent against multidrug resistant (MDR) bacteria.
Developed by researchers at the University of Melbourne (UNIMELB; Parkville, Australia), the star-shaped SNAPP is extremely effective at killing Gram-negative bacteria while being non-toxic to the body’s own cells, thanks to its unique antimicrobial activity. SNAPPs induce cell death by a multimodal mechanism that combines outer membrane destabilization, unregulated ion movement across the cytoplasmic membrane, and induction of the apoptotic-like death pathway.
The SNAPPs exhibited sub-μM activity against all Gram-negative bacteria tested, including the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter, Pseudomonas aeruginosa and Enterobacter) pathogens and other colistin-resistant and MDR (CMDR) pathogens, while demonstrating low toxicity. In addition, the researchers did not observe any resistance acquisition by A. baumannii (including the CMDR strain) to SNAPPs. The study was published on September 12, 2016, in Nature Microbiology.
“It is estimated that the rise of superbugs will cause up to ten million deaths a year by 2050. In addition, there have only been one or two new antibiotics developed in the last 30 years,” concluded senior author Professor Greg Qiao, PhD, of the department of chemical and biomolecular engineering, and colleagues. “Overall, SNAPPs show great promise as low-cost and effective antimicrobial agents, and may represent a weapon in combating the growing threat of MDR Gram-negative bacteria.”
Antimicrobial polymers are engineered to mimic peptides used by the immune systems of living things to kill bacteria. Typically, they are produced by attaching or inserting an active antimicrobial agent onto a polymer backbone via an alkyl or acetyl linker. The use of antimicrobial polymers may enhance the efficiency and selectivity of common antimicrobial agents, while decreasing associated environmental hazards since they are generally nonvolatile and chemically stable.
Related Links:
University of Melbourne
		
			
			
		
        		        
		        Developed by researchers at the University of Melbourne (UNIMELB; Parkville, Australia), the star-shaped SNAPP is extremely effective at killing Gram-negative bacteria while being non-toxic to the body’s own cells, thanks to its unique antimicrobial activity. SNAPPs induce cell death by a multimodal mechanism that combines outer membrane destabilization, unregulated ion movement across the cytoplasmic membrane, and induction of the apoptotic-like death pathway.
The SNAPPs exhibited sub-μM activity against all Gram-negative bacteria tested, including the ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter, Pseudomonas aeruginosa and Enterobacter) pathogens and other colistin-resistant and MDR (CMDR) pathogens, while demonstrating low toxicity. In addition, the researchers did not observe any resistance acquisition by A. baumannii (including the CMDR strain) to SNAPPs. The study was published on September 12, 2016, in Nature Microbiology.
“It is estimated that the rise of superbugs will cause up to ten million deaths a year by 2050. In addition, there have only been one or two new antibiotics developed in the last 30 years,” concluded senior author Professor Greg Qiao, PhD, of the department of chemical and biomolecular engineering, and colleagues. “Overall, SNAPPs show great promise as low-cost and effective antimicrobial agents, and may represent a weapon in combating the growing threat of MDR Gram-negative bacteria.”
Antimicrobial polymers are engineered to mimic peptides used by the immune systems of living things to kill bacteria. Typically, they are produced by attaching or inserting an active antimicrobial agent onto a polymer backbone via an alkyl or acetyl linker. The use of antimicrobial polymers may enhance the efficiency and selectivity of common antimicrobial agents, while decreasing associated environmental hazards since they are generally nonvolatile and chemically stable.
Related Links:
University of Melbourne
Latest Critical Care News
- 'Universal' Kidney to Match Any Blood Type
- Light-Based Technology to Measure Brain Blood Flow Could Diagnose Stroke and TBI
- AI Heart Attack Risk Assessment Tool Outperforms Existing Methods
- Smartphone Imaging System Enables Early Oral Cancer Detection
- Swallowable Pill-Sized Bioprinter Treats GI Tract Injuries  
- Personalized Brain “Pacemakers” Could Help Patients with Hard-To-Treat Epilepsy
- Microscopic DNA Flower Robots to Enable Precision Medicine Delivery
- Origami Robots to Deliver Medicine Less Invasively and More Effectively
- Improved Cough-Detection Technology Aids Health Monitoring
- AI Identifies Children in ER Likely to Develop Sepsis Within 48 Hours
- New Radiofrequency Therapy Slows Glioblastoma Growth
- Battery-Free Wireless Multi-Sensing Platform Revolutionizes Pressure Injury Detection
- Multimodal AI to Revolutionize Cardiovascular Disease Diagnosis and Treatment
- AI System Reveals Hidden Diagnostic Patterns in Electronic Health Records
- Highly Sensitive On-Skin Sensing Monitor Detects Vitamin B6 and Glucose in Sweat
- Artificial Intelligence Revolutionizing Pediatric Anesthesia Management
Channels
Surgical Techniques
view channel 
                    Minimally Invasive Endoscopic Surgery Improves Severe Stroke Outcomes
Intracerebral hemorrhage, a type of stroke caused by bleeding deep within the brain, remains one of the most challenging neurological emergencies to treat. Accounting for about 15% of all strokes, it carries... Read more 
                    Novel Glue Prevents Complications After Breast Cancer Surgery
Seroma and prolonged lymphorrhea are among the most common complications following axillary lymphadenectomy in breast cancer patients. These postoperative issues can delay recovery and postpone the start... Read morePatient Care
view channel 
                    Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more 
                    VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more 
                    Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more 
                    First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel 
                    Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel 
                    Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more 
                    B. Braun Acquires Digital Microsurgery Company True Digital Surgery
The high-end microsurgery market in neurosurgery, spine, and ENT is undergoing a significant transformation. Traditional analog microscopes are giving way to digital exoscopes, which provide improved visualization,... Read more 
                    CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
The 92nd China International Medical Equipment Fair (CMEF 2025) Autumn Exhibition is scheduled to be held from September 26 to 29 at the China Import and Export Fair Complex (Canton Fair Complex) in Guangzhou.... Read more 
                    















 
								

 
								
 
								 
                     
                     
                    